Selected Publications
Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthuis PT, Loughin T, McCandless LC, Platt RW, Schnepel KT, Socías ME.: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder JAMA : 2024.
Thakrar AP, Christine PJ, Siaw-Asamoah A, Spadaro A, Faude S, Snider CK, Delgado MK, Lowenstein M, Kampman K, Perrone J, Nelson LS, Kilaru AS.: Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl JAMA Netw Open 7 : e2435895,2024.
Shi Z, Li X, Kampman KM, Childress AR, Wiers CE, Langleben DD.: Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder J Clin Psychiatry 84 : 22br14567,2023.
Stewart RE, Cardamone NC, Mandell DS, Kwon N, Kampman KM, Knudsen HK, Tjoa CW, Marcus SC.: Not in my treatment center: Leadership's perception of barriers to MOUD adoption J Subst Abuse Treat : 2023.
French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB.: Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care Fam Syst Health : 2023.
Dugosh KL, Lent MR, Burkley SB, Millard CMK, McKay JR, Kampman KM.: Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment J Addict Med : 2023.
Krouse RA, Morales KH, Kampman KM, Chakravorty S.: The role of baseline insomnia in moderating the hypnotic properties of quetiapine Addict Behav : 2023.
114., Kuijper MF, Mahajan UV, Ku S, Barbosa DAN, Alessi SM, Stein SE, Kampman KM, Bentzley BS, Halpern CH: Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost-Effectiveness Analysis Neuromodulation 25 (2): 2022.
Lynch KG, Plebani, J, Spratt K, Morales M, Tamminga M, Feibush P, Kampman KM.: Varenicline for the Treatment of Cocaine Dependence J addict J addict. Med 16 (2): 2022.
Lynch KG, Plebani, J, Spratt K, Morales M, Tamminga M, Feibush P, Kampman KM.: Varenicline for the Treatment of Cocaine Dependence J addict J addict. Med 16 (2): 2022.
Academic Contact Information
University of Pennsylvania
Center for Studies of Addiction
3535 market Street
Philadelphia,
PA
19104
Phone: 215-746-2764
Patient appointments: 866-301-4724